Estimation of Impact of Implementing Pre-emptive Pharmacogenetic Testing in Hospital Treated Patients in Finland

被引：0

作者：

Kulla, N. ^{[1
,2
]}

Cajanus, K. ^{[1
,2
]}

Kyto, V ^{[3
,4
,5
]}

Niemi, M. ^{[6
,7
,8
]}

Tornio, A. ^{[1
,2
]}

机构：

[1] Univ Turku, Inst Biomed, Integrat Physiol & Pharmacol, Turku, Finland

[2] Turku Univ Hosp, Unit Clin Pharmacol, Turku, Finland

[3] Turku Univ Hosp, Heart Ctr, Turku, Finland

[4] Univ Turku, Turku, Finland

[5] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland

[6] Univ Helsinki, Dept Clin Pharmacol, Individualized Drug Therapy Res Program, Helsinki, Finland

[7] Helsinki Univ Hosp, HUS Diagnost Ctr, Helsinki, Finland

[8] Univ Helsinki, Individualized Drug Therapy Res Program, Helsinki, Finland

来源：

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

236

引用

页码：S101 / S101

页数：1